|
G |
ABCB1 |
ATP binding cassette subfamily B member 1 |
decreases activity multiple interactions increases expression affects activity |
EXP ISO |
chrysin results in decreased activity of ABCB1 protein [chrysin results in decreased activity of ABCB1 protein] which results in decreased export of Topotecan chrysin results in increased expression of ABCB1 protein chrysin affects the activity of ABCB1 protein |
CTD |
PMID:15796199 PMID:20457140 PMID:27996361 |
|
NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
|
|
G |
ABCC1 |
ATP binding cassette subfamily C member 1 (ABCC1 blood group) |
multiple interactions |
EXP |
ABCC1 protein affects the reaction [chrysin results in increased transport of Glutathione] |
CTD |
PMID:21856323 |
|
NCBI chr16:15,949,143...16,143,053
Ensembl chr16:15,949,138...16,143,257
|
|
G |
ABCC2 |
ATP binding cassette subfamily C member 2 |
multiple interactions increases expression decreases activity |
EXP |
[chrysin results in decreased activity of ABCC2 protein] which results in decreased export of Topotecan; chrysin inhibits the reaction [ABCC2 protein affects the export of ochratoxin A] chrysin results in increased expression of ABCC2 protein |
CTD |
PMID:15955639 PMID:20457140 |
|
NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594
|
|
G |
ABCC3 |
ATP binding cassette subfamily C member 3 |
multiple interactions |
EXP |
ABCC3 protein affects the reaction [chrysin results in increased transport of Glutathione] |
CTD |
PMID:21856323 |
|
NCBI chr17:50,634,881...50,692,253
Ensembl chr17:50,634,777...50,692,253
|
|
G |
ABCC5 |
ATP binding cassette subfamily C member 5 |
multiple interactions decreases expression |
EXP |
ABCC5 protein affects the reaction [chrysin results in increased transport of Glutathione] chrysin results in decreased expression of ABCC5 mRNA; chrysin results in decreased expression of ABCC5 protein |
CTD |
PMID:21856323 PMID:23994249 |
|
NCBI chr 3:183,919,934...184,017,884
Ensembl chr 3:183,919,934...184,017,939
|
|
G |
ABCG2 |
ATP binding cassette subfamily G member 2 (JR blood group) |
multiple interactions decreases activity increases expression decreases expression |
EXP ISO |
[chrysin results in decreased activity of ABCG2 protein] which results in decreased export of Topotecan; chrysin inhibits the reaction [ABCG2 protein results in increased secretion of Mitoxantrone]; chrysin inhibits the reaction [ABCG2 protein results in increased transport of Nitrofurantoin] chrysin results in increased expression of ABCG2 mRNA; chrysin results in increased expression of ABCG2 protein chrysin results in decreased expression of ABCG2 mRNA chrysin inhibits the reaction [ABCG2 protein affects the transport of Nitrofurantoin] |
CTD |
PMID:17077187 PMID:17093006 PMID:19732493 PMID:20457140 PMID:20816778 |
|
NCBI chr 4:88,090,264...88,231,626
Ensembl chr 4:88,090,150...88,231,628
|
|
G |
ACHE |
acetylcholinesterase (Yt blood group) |
multiple interactions |
ISO |
chrysin inhibits the reaction [Aluminum Chloride results in increased activity of ACHE protein] |
CTD |
PMID:34774662 |
|
NCBI chr 7:100,889,994...100,896,994
Ensembl chr 7:100,889,994...100,896,974
|
|
G |
ACTA2 |
actin alpha 2, smooth muscle |
multiple interactions |
ISO |
chrysin inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 mRNA] |
CTD |
PMID:26297989 |
|
NCBI chr10:88,935,074...88,991,337
Ensembl chr10:88,935,074...88,991,339
|
|
G |
ADIPOQ |
adiponectin, C1Q and collagen domain containing |
increases expression |
ISO |
chrysin results in increased expression of ADIPOQ protein |
CTD |
PMID:30445784 |
|
NCBI chr 3:186,842,710...186,858,463
Ensembl chr 3:186,842,704...186,858,463
|
|
G |
AFP |
alpha fetoprotein |
affects binding |
ISO |
chrysin binds to AFP protein |
CTD |
PMID:23013281 PMID:25349334 |
|
NCBI chr 4:73,436,221...73,456,174
Ensembl chr 4:73,431,138...73,456,174
|
|
G |
AHR |
aryl hydrocarbon receptor |
affects activity multiple interactions |
EXP ISO |
chrysin affects the activity of AHR protein chrysin binds to and results in increased activity of AHR protein [chrysin co-treated with Methylcholanthrene] affects the activity of AHR protein; [chrysin co-treated with Tetrachlorodibenzodioxin] affects the activity of AHR protein; chrysin binds to and results in increased activity of AHR protein; chrysin inhibits the reaction [AHR protein binds to CYP1A1 promoter]; chrysin inhibits the reaction [AHR protein binds to UGT1A1 promoter]; chrysin inhibits the reaction [Tetrachlorodibenzodioxin binds to AHR protein]; chrysin promotes the reaction [AHR protein binds to CYP1A1 promoter] |
CTD |
PMID:14644660 PMID:16972788 PMID:17256720 PMID:19286049 |
|
NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152
|
|
G |
AKR1B10 |
aldo-keto reductase family 1 member B10 |
decreases expression |
EXP |
chrysin results in decreased expression of AKR1B10 mRNA; chrysin results in decreased expression of AKR1B10 protein |
CTD |
PMID:23994249 |
|
NCBI chr 7:134,527,567...134,541,412
Ensembl chr 7:134,527,567...134,541,412
|
|
G |
AKT1 |
AKT serine/threonine kinase 1 |
multiple interactions decreases phosphorylation |
EXP |
BCL2 protein inhibits the reaction [chrysin results in decreased phosphorylation of and results in decreased activity of AKT1 protein]; chrysin inhibits the reaction [AKT1 protein results in increased expression of MMP10 protein]; chrysin inhibits the reaction [AKT1 protein results in increased expression of SNAI1 protein]; chrysin results in decreased phosphorylation of and results in decreased activity of AKT1 protein chrysin results in decreased phosphorylation of AKT1 protein |
CTD |
PMID:16215670 PMID:18455702 PMID:24122885 PMID:30578657 |
|
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,751
|
|
G |
ALB |
albumin |
multiple interactions |
ISO |
chrysin inhibits the reaction [Acetaminophen results in decreased expression of ALB protein] |
CTD |
PMID:30794797 |
|
NCBI chr 4:73,404,287...73,421,482
Ensembl chr 4:73,397,114...73,421,482
|
|
G |
APOB |
apolipoprotein B |
multiple interactions |
ISO |
chrysin inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in decreased expression of APOB mRNA]; chrysin inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in decreased expression of APOB protein] |
CTD |
PMID:32220030 |
|
NCBI chr 2:21,001,429...21,044,073
Ensembl chr 2:21,001,429...21,044,073
|
|
G |
ARNT |
aryl hydrocarbon receptor nuclear translocator |
multiple interactions |
EXP |
chrysin promotes the reaction [ARNT protein binds to CYP1A1 promoter] |
CTD |
PMID:16972788 |
|
NCBI chr 1:150,809,713...150,876,599
Ensembl chr 1:150,809,713...150,876,708
|
|
G |
ARRB2 |
arrestin beta 2 |
multiple interactions |
ISO |
chrysin inhibits the reaction [Diethylnitrosamine results in increased expression of ARRB2 mRNA]; chrysin inhibits the reaction [Diethylnitrosamine results in increased expression of ARRB2 protein] |
CTD |
PMID:21167192 |
|
NCBI chr17:4,710,632...4,721,497
Ensembl chr17:4,710,596...4,721,499
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
multiple interactions |
ISO EXP |
chrysin inhibits the reaction [Isoniazid results in increased expression of BAX protein]; chrysin inhibits the reaction [Testosterone results in decreased expression of BAX mRNA]; chrysin promotes the reaction [Diethylnitrosamine results in increased expression of BAX protein] [Cisplatin co-treated with chrysin] results in increased expression of BAX protein |
CTD |
PMID:21167192 PMID:25770930 PMID:29247772 PMID:33121995 |
|
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
|
|
G |
BCHE |
butyrylcholinesterase |
multiple interactions |
ISO |
chrysin inhibits the reaction [Aluminum Chloride results in increased activity of BCHE protein] |
CTD |
PMID:34774662 |
|
NCBI chr 3:165,772,904...165,837,423
Ensembl chr 3:165,772,904...165,837,462
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
multiple interactions decreases response to substance |
EXP ISO |
BCL2 protein inhibits the reaction [chrysin results in decreased expression of XIAP protein]; BCL2 protein inhibits the reaction [chrysin results in decreased phosphorylation of and results in decreased activity of AKT1 protein]; BCL2 protein inhibits the reaction [chrysin results in increased cleavage of and results in increased activity of CASP3 protein]; BCL2 protein inhibits the reaction [chrysin results in increased degradation of PLCG1 protein]; chrysin inhibits the reaction [Cisplatin results in increased expression of BCL2 protein] chrysin inhibits the reaction [Testosterone results in increased expression of BCL2 mRNA] BCL2 protein results in decreased susceptibility to chrysin |
CTD |
PMID:16215670 PMID:25770930 PMID:29247772 |
|
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
|
|
G |
BCL2L1 |
BCL2 like 1 |
multiple interactions |
ISO |
chrysin inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2L1 mRNA]; chrysin inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2L1 protein] |
CTD |
PMID:21167192 |
|
NCBI chr20:31,664,452...31,723,963
Ensembl chr20:31,664,452...31,723,989
|
|
G |
BDNF |
brain derived neurotrophic factor |
multiple interactions increases expression |
ISO |
chrysin inhibits the reaction [Oxidopamine results in decreased expression of BDNF protein] chrysin results in increased expression of BDNF protein |
CTD |
PMID:29054324 |
|
NCBI chr11:27,654,893...27,722,030
Ensembl chr11:27,654,893...27,722,058
|
|
G |
CASP1 |
caspase 1 |
multiple interactions |
EXP |
chrysin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased activity of CASP1 protein] |
CTD |
PMID:21515303 |
|
NCBI chr11:105,025,443...105,036,686
Ensembl chr11:105,025,397...105,035,250
|
|
G |
CASP3 |
caspase 3 |
multiple interactions increases cleavage |
EXP ISO |
[Cisplatin co-treated with chrysin] results in increased cleavage of CASP3 protein; BCL2 protein inhibits the reaction [chrysin results in increased cleavage of and results in increased activity of CASP3 protein]; benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[Cisplatin co-treated with chrysin] results in increased cleavage of CASP3 protein]; chrysin inhibits the reaction [Topotecan results in increased activity of CASP3 protein]; chrysin promotes the reaction [TNFSF10 protein results in increased degradation of CASP3 protein]; chrysin results in increased cleavage of and results in increased activity of CASP3 protein chrysin results in increased cleavage of CASP3 protein [Diethylnitrosamine co-treated with chrysin] results in increased expression of CASP3 protein; chrysin inhibits the reaction [Acetaminophen results in increased activity of CASP3 protein]; chrysin inhibits the reaction [Colistin results in increased expression of CASP3 protein]; chrysin inhibits the reaction [Freund's Adjuvant results in increased activity of CASP3 protein]; chrysin inhibits the reaction [Testosterone results in decreased cleavage of CASP3 protein]; chrysin inhibits the reaction [Thioacetamide results in increased expression of CASP3 protein] |
CTD |
PMID:16215670 PMID:18331776 PMID:19397994 PMID:20457140 PMID:21167192 PMID:21195158 PMID:24932515 PMID:25770930 PMID:28682524 PMID:29247772 PMID:30273961 PMID:30500344 More...
|
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
CASP8 |
caspase 8 |
multiple interactions increases cleavage |
EXP |
[Cisplatin co-treated with chrysin] results in increased cleavage of CASP8 protein; chrysin inhibits the reaction [Topotecan results in increased activity of CASP8 protein]; chrysin promotes the reaction [TNFSF10 protein results in increased degradation of CASP8 protein] chrysin results in increased cleavage of CASP8 protein |
CTD |
PMID:20457140 PMID:21195158 PMID:25770930 |
|
NCBI chr 2:201,233,463...201,287,711
Ensembl chr 2:201,233,443...201,361,836
|
|
G |
CASP9 |
caspase 9 |
increases cleavage multiple interactions |
EXP |
chrysin results in increased cleavage of CASP9 protein [Cisplatin co-treated with chrysin] results in increased cleavage of CASP9 protein |
CTD |
PMID:18331776 PMID:25770930 |
|
NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
|
|
G |
CAT |
catalase |
multiple interactions decreases activity |
ISO |
chrysin inhibits the reaction [Acetaminophen results in decreased activity of CAT protein]; chrysin inhibits the reaction [Colistin results in decreased activity of CAT protein]; chrysin inhibits the reaction [ferric nitrilotriacetate results in decreased activity of CAT protein]; chrysin inhibits the reaction [Isoniazid results in decreased activity of CAT protein]; chrysin inhibits the reaction [Testosterone results in decreased activity of CAT protein] chrysin inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in decreased activity of CAT protein]; chrysin inhibits the reaction [Aluminum Chloride results in decreased activity of CAT protein] chrysin results in decreased activity of CAT protein |
CTD |
PMID:10647909 PMID:23194824 PMID:28682524 PMID:29247772 PMID:30273961 PMID:32220030 PMID:33121995 PMID:34774662 More...
|
|
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
|
|
G |
CCNB1 |
cyclin B1 |
decreases expression |
EXP |
chrysin results in decreased expression of CCNB1 mRNA; chrysin results in decreased expression of CCNB1 protein |
CTD |
PMID:18331776 PMID:19397994 |
|
NCBI chr 5:69,167,150...69,178,245
Ensembl chr 5:69,167,135...69,178,245
|
|
G |
CDH1 |
cadherin 1 |
increases expression |
EXP |
chrysin results in increased expression of CDH1 protein |
CTD |
PMID:24122885 PMID:30578657 |
|
NCBI chr16:68,737,292...68,835,537
Ensembl chr16:68,737,292...68,835,537
|
|
G |
CDH2 |
cadherin 2 |
decreases expression |
EXP |
chrysin results in decreased expression of CDH2 protein |
CTD |
PMID:30578657 |
|
NCBI chr18:27,932,879...28,177,130
Ensembl chr18:27,932,879...28,177,946
|
|
G |
CDKN1A |
cyclin dependent kinase inhibitor 1A |
increases expression multiple interactions |
EXP ISO |
chrysin results in increased expression of CDKN1A mRNA; chrysin results in increased expression of CDKN1A protein chrysin inhibits the reaction [Testosterone results in decreased expression of CDKN1A mRNA] |
CTD |
PMID:19397994 PMID:29247772 |
|
NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,337
|
|
G |
CDKN2C |
cyclin dependent kinase inhibitor 2C |
decreases expression |
EXP |
chrysin results in decreased expression of CDKN2C mRNA |
CTD |
PMID:18331776 |
|
NCBI chr 1:50,968,706...50,974,634
Ensembl chr 1:50,960,745...50,974,634
|
|
G |
CEBPA |
CCAAT enhancer binding protein alpha |
increases expression |
ISO |
chrysin results in increased expression of CEBPA protein |
CTD |
PMID:30445784 |
|
NCBI chr19:33,299,934...33,302,534
Ensembl chr19:33,299,934...33,302,534
|
|
G |
CTNNB1 |
catenin beta 1 |
multiple interactions |
EXP |
chrysin inhibits the reaction [Topotecan results in increased cleavage of CTNNB1 protein] |
CTD |
PMID:20457140 |
|
NCBI chr 3:41,199,505...41,240,443
Ensembl chr 3:41,194,741...41,260,096
|
|
G |
CXCL10 |
C-X-C motif chemokine ligand 10 |
multiple interactions |
ISO |
chrysin inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL10 mRNA]; chrysin inhibits the reaction [Poly I-C results in increased expression of CXCL10 mRNA] |
CTD |
PMID:19426678 |
|
NCBI chr 4:76,021,118...76,023,497
Ensembl chr 4:76,021,118...76,023,497
|
|
G |
CXCL8 |
C-X-C motif chemokine ligand 8 |
multiple interactions increases expression |
EXP |
chrysin inhibits the reaction [IL1B protein results in increased secretion of CXCL8 protein] chrysin results in increased expression of CXCL8 mRNA |
CTD |
PMID:18377686 PMID:18457675 |
|
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
|
|
G |
CYP19A1 |
cytochrome P450 family 19 subfamily A member 1 |
decreases activity multiple interactions |
EXP |
chrysin results in decreased activity of CYP19A1 protein chrysin binds to and results in decreased activity of CYP19A1 protein |
CTD |
PMID:9435150 PMID:10403137 PMID:15319488 |
|
NCBI chr15:51,208,057...51,338,596
Ensembl chr15:51,208,057...51,338,601
|
|
G |
CYP1A1 |
cytochrome P450 family 1 subfamily A member 1 |
multiple interactions increases oxidation increases expression increases metabolic processing decreases activity increases activity |
EXP ISO |
[CYP1A1 protein results in increased metabolism of chrysin] which results in increased chemical synthesis of baicalein; chrysin inhibits the reaction [AHR protein binds to CYP1A1 promoter]; chrysin inhibits the reaction [CYP1A1 results in increased activity of Benzo(a)pyrene]; chrysin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein]; chrysin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]; chrysin promotes the reaction [AHR protein binds to CYP1A1 promoter]; chrysin promotes the reaction [ARNT protein binds to CYP1A1 promoter]; chrysin promotes the reaction [ESR1 protein binds to CYP1A1 promoter] CYP1A1 protein results in increased oxidation of chrysin chrysin results in increased expression of CYP1A1 mRNA chrysin promotes the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA] chrysin results in increased expression of CYP1A1 mRNA; chrysin results in increased expression of CYP1A1 protein chrysin results in decreased activity of CYP1A1 protein chrysin results in increased activity of CYP1A1 protein |
CTD |
PMID:11752233 PMID:16972788 PMID:17012224 PMID:17256720 PMID:19666078 PMID:19766177 PMID:20816778 PMID:20930378 PMID:21053930 PMID:21482471 PMID:30964977 More...
|
|
NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
|
|
G |
CYP1A2 |
cytochrome P450 family 1 subfamily A member 2 |
increases metabolic processing increases oxidation multiple interactions decreases activity |
EXP |
CYP1A2 protein results in increased metabolism of chrysin CYP1A2 protein results in increased oxidation of chrysin [CYP1A2 protein results in increased metabolism of chrysin] which results in increased chemical synthesis of baicalein chrysin results in decreased activity of CYP1A2 protein |
CTD |
PMID:19666078 PMID:20806393 PMID:21053930 PMID:30964977 |
|
NCBI chr15:74,748,845...74,756,607
Ensembl chr15:74,748,845...74,756,607
|
|
G |
CYP1B1 |
cytochrome P450 family 1 subfamily B member 1 |
multiple interactions increases oxidation increases metabolic processing decreases activity |
EXP |
[CYP1B1 protein results in increased metabolism of chrysin] which results in increased chemical synthesis of baicalein; chrysin binds to and results in decreased activity of CYP1B1 protein CYP1B1 protein alternative form results in increased oxidation of chrysin chrysin results in decreased activity of CYP1B1 protein |
CTD |
PMID:19666078 PMID:21053930 PMID:21482471 PMID:30964977 |
|
NCBI chr 2:38,067,509...38,076,151
Ensembl chr 2:38,066,973...38,109,902
|
|
G |
CYP2A13 |
cytochrome P450 family 2 subfamily A member 13 |
increases oxidation |
EXP |
CYP2A13 protein results in increased oxidation of chrysin |
CTD |
PMID:30964977 |
|
NCBI chr19:41,088,451...41,096,195
Ensembl chr19:41,088,451...41,096,195
|
|
G |
CYP2A6 |
cytochrome P450 family 2 subfamily A member 6 |
multiple interactions |
EXP |
[CYP2A6 protein co-treated with POR protein] results in increased oxidation of chrysin |
CTD |
PMID:30964977 |
|
NCBI chr19:40,843,541...40,850,447
Ensembl chr19:40,843,541...40,850,447
|
|
G |
CYP2B6 |
cytochrome P450 family 2 subfamily B member 6 |
multiple interactions increases expression |
ISO EXP |
NR1I3 gene mutant form inhibits the reaction [chrysin results in increased expression of CYP2B10 mRNA] chrysin results in increased expression of CYP2B6 mRNA |
CTD |
PMID:25625231 |
|
NCBI chr19:40,991,282...41,018,398
Ensembl chr19:40,991,282...41,018,398
|
|
G |
CYP2C9 |
cytochrome P450 family 2 subfamily C member 9 |
multiple interactions |
EXP |
chrysin inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen] |
CTD |
PMID:21053930 |
|
NCBI chr10:94,938,658...94,990,091
Ensembl chr10:94,938,658...94,990,091
|
|
G |
CYP3A4 |
cytochrome P450 family 3 subfamily A member 4 |
multiple interactions increases activity |
EXP |
[[chrysin results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam; [chrysin results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam; chrysin binds to and results in decreased activity of CYP3A4 protein; chrysin inhibits the reaction [Calcitriol results in increased activity of CYP3A4 protein] |
CTD |
PMID:19766177 PMID:21053930 PMID:31756459 |
|
NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248
|
|
G |
EDN1 |
endothelin 1 |
increases expression |
EXP |
chrysin results in increased expression of EDN1 mRNA |
CTD |
PMID:18457675 |
|
NCBI chr 6:12,230,516...12,297,194
Ensembl chr 6:12,290,361...12,297,194
|
|
G |
EGF |
epidermal growth factor |
multiple interactions |
EXP |
chrysin inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein]; chrysin inhibits the reaction [EGF protein results in increased phosphorylation of ELK1 protein] |
CTD |
PMID:25625231 |
|
NCBI chr 4:109,912,883...110,013,766
Ensembl chr 4:109,912,883...110,013,766
|
|
G |
EGFR |
epidermal growth factor receptor |
multiple interactions |
EXP |
chrysin inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein] |
CTD |
PMID:25625231 |
|
NCBI chr 7:55,019,017...55,211,628
Ensembl chr 7:55,019,017...55,211,628
|
|
G |
ELK1 |
ETS transcription factor ELK1 |
multiple interactions |
EXP |
chrysin inhibits the reaction [EGF protein results in increased phosphorylation of ELK1 protein] |
CTD |
PMID:25625231 |
|
NCBI chr X:47,635,520...47,650,604
Ensembl chr X:47,635,521...47,650,604
|
|
G |
EPO |
erythropoietin |
increases expression |
EXP |
chrysin results in increased expression of EPO mRNA |
CTD |
PMID:37348668 |
|
NCBI chr 7:100,720,468...100,723,700
Ensembl chr 7:100,720,468...100,723,700
|
|
G |
ESR1 |
estrogen receptor 1 |
multiple interactions |
EXP |
chrysin binds to and results in increased activity of ESR1 protein; chrysin promotes the reaction [ESR1 protein binds to CYP1A1 promoter]; chrysin promotes the reaction [ESR1 protein binds to TFF1 promoter] |
CTD |
PMID:9751507 PMID:16972788 PMID:29162470 PMID:33049310 |
|
NCBI chr 6:151,656,672...152,129,619
Ensembl chr 6:151,656,691...152,129,619
|
|
G |
ESR2 |
estrogen receptor 2 |
affects binding multiple interactions |
EXP |
chrysin binds to ESR2 protein chrysin binds to and results in increased activity of ESR2 protein |
CTD |
PMID:9751507 PMID:12224631 PMID:33049310 |
|
NCBI chr14:64,226,707...64,338,613
Ensembl chr14:64,084,232...64,338,112
|
|
G |
FADS2 |
fatty acid desaturase 2 |
decreases expression |
EXP |
chrysin results in decreased expression of FADS2 mRNA |
CTD |
PMID:20816778 |
|
NCBI chr11:61,816,203...61,867,354
Ensembl chr11:61,792,980...61,867,354
|
|
G |
FASLG |
Fas ligand |
multiple interactions |
ISO |
chrysin inhibits the reaction [Freund's Adjuvant results in increased expression of FASLG mRNA] |
CTD |
PMID:24932515 |
|
NCBI chr 1:172,659,103...172,666,876
Ensembl chr 1:172,659,103...172,666,876
|
|
G |
FBP1 |
fructose-bisphosphatase 1 |
decreases expression |
EXP |
chrysin results in decreased expression of FBP1 mRNA |
CTD |
PMID:18331776 |
|
NCBI chr 9:94,603,133...94,640,263
Ensembl chr 9:94,603,133...94,640,249
|
|
G |
FN1 |
fibronectin 1 |
increases expression |
EXP |
chrysin results in increased expression of FN1 protein |
CTD |
PMID:26408079 |
|
NCBI chr 2:215,360,865...215,436,068
Ensembl chr 2:215,360,440...215,436,073
|
|
G |
FOS |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
EXP |
chrysin inhibits the reaction [TNF protein results in increased activity of [FOS protein binds to JUN protein]] |
CTD |
PMID:15322261 |
|
NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,282,230
|
|
G |
FOXP3 |
forkhead box P3 |
multiple interactions |
ISO |
chrysin inhibits the reaction [Diazinon results in decreased expression of FOXP3 mRNA] |
CTD |
PMID:36114367 |
|
NCBI chr X:49,250,438...49,264,710
Ensembl chr X:49,250,438...49,264,800
|
|
G |
FSHB |
follicle stimulating hormone subunit beta |
multiple interactions |
ISO |
chrysin inhibits the reaction [Freund's Adjuvant results in increased expression of FSHB protein] |
CTD |
PMID:24932515 |
|
NCBI chr11:30,231,014...30,235,194
Ensembl chr11:30,231,014...30,235,261
|
|
G |
GADD45B |
growth arrest and DNA damage inducible beta |
increases expression |
EXP |
chrysin results in increased expression of GADD45B mRNA; chrysin results in increased expression of GADD45B protein |
CTD |
PMID:18331776 |
|
NCBI chr19:2,476,127...2,478,257
Ensembl chr19:2,476,122...2,478,259
|
|
G |
GATA3 |
GATA binding protein 3 |
multiple interactions |
ISO |
chrysin inhibits the reaction [Diazinon results in increased expression of GATA3 mRNA] |
CTD |
PMID:36114367 |
|
NCBI chr10:8,045,333...8,075,198
Ensembl chr10:8,045,378...8,075,198
|
|
G |
GCLC |
glutamate-cysteine ligase catalytic subunit |
multiple interactions increases expression |
ISO |
[Buthionine Sulfoximine results in decreased activity of [GCLC protein binds to GCLM protein]] inhibits the reaction [chrysin inhibits the reaction [tert-Butylhydroperoxide results in increased chemical synthesis of Reactive Oxygen Species]]; [chrysin results in increased expression of GCLC mRNA] which results in decreased susceptibility to tert-Butylhydroperoxide; chrysin inhibits the reaction [Isoniazid results in increased expression of GCLC mRNA]; MAPK1 protein affects the reaction [chrysin results in increased expression of GCLC protein]; NFE2L2 protein affects the reaction [chrysin results in increased expression of GCLC protein] chrysin results in increased expression of GCLC mRNA; chrysin results in increased expression of GCLC protein |
CTD |
PMID:22864849 PMID:33121995 |
|
NCBI chr 6:53,497,341...53,545,101
Ensembl chr 6:53,497,341...53,616,970
|
|
G |
GCLM |
glutamate-cysteine ligase modifier subunit |
multiple interactions increases expression |
ISO |
[Buthionine Sulfoximine results in decreased activity of [GCLC protein binds to GCLM protein]] inhibits the reaction [chrysin inhibits the reaction [tert-Butylhydroperoxide results in increased chemical synthesis of Reactive Oxygen Species]]; [chrysin results in increased expression of GCLM mRNA] which results in decreased susceptibility to tert-Butylhydroperoxide; chrysin inhibits the reaction [Isoniazid results in increased expression of GCLM mRNA]; MAPK1 protein affects the reaction [chrysin results in increased expression of GCLM protein]; NFE2L2 protein affects the reaction [chrysin results in increased expression of GCLM protein] chrysin results in increased expression of GCLM mRNA; chrysin results in increased expression of GCLM protein |
CTD |
PMID:22864849 PMID:33121995 |
|
NCBI chr 1:93,885,199...93,909,430
Ensembl chr 1:93,885,199...93,909,456
|
|
G |
GDNF |
glial cell derived neurotrophic factor |
multiple interactions |
ISO |
chrysin inhibits the reaction [Oxidopamine results in decreased expression of GDNF protein] |
CTD |
PMID:29054324 |
|
NCBI chr 5:37,812,677...37,840,041
Ensembl chr 5:37,812,677...37,840,041
|
|
G |
GFAP |
glial fibrillary acidic protein |
multiple interactions |
ISO |
chrysin inhibits the reaction [Isoniazid results in increased expression of GFAP mRNA]; chrysin inhibits the reaction [Isoniazid results in increased expression of GFAP protein] |
CTD |
PMID:33121995 |
|
NCBI chr17:44,903,159...44,915,500
Ensembl chr17:44,903,159...44,916,937
|
|
G |
GPT |
glutamic--pyruvic transaminase |
multiple interactions |
ISO |
chrysin inhibits the reaction [Acetaminophen results in increased activity of GPT protein]; chrysin inhibits the reaction [Acetaminophen results in increased expression of GPT protein] |
CTD |
PMID:28682524 PMID:30794797 PMID:31625388 |
|
NCBI chr 8:144,503,068...144,507,172
Ensembl chr 8:144,502,973...144,507,174
|
|
G |
GRB2 |
growth factor receptor bound protein 2 |
decreases expression |
EXP |
chrysin results in decreased expression of GRB2 protein |
CTD |
PMID:30578657 |
|
NCBI chr17:75,318,076...75,405,678
Ensembl chr17:75,318,076...75,405,709
|
|
G |
GREB1 |
growth regulating estrogen receptor binding 1 |
multiple interactions increases expression |
EXP |
Fulvestrant inhibits the reaction [chrysin results in increased expression of GREB1 mRNA] |
CTD |
PMID:33405908 |
|
NCBI chr 2:11,482,888...11,642,788
Ensembl chr 2:11,482,341...11,642,788
|
|
G |
GSR |
glutathione-disulfide reductase |
decreases activity |
ISO |
chrysin results in decreased activity of GSR protein |
CTD |
PMID:10647909 |
|
NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846
|
|
G |
HIF1A |
hypoxia inducible factor 1 subunit alpha |
multiple interactions increases expression |
EXP |
chrysin results in decreased degradation of and results in increased expression of HIF1A protein modified form chrysin results in increased expression of HIF1A mRNA; chrysin results in increased expression of HIF1A protein |
CTD |
PMID:37348668 |
|
NCBI chr14:61,695,513...61,748,258
Ensembl chr14:61,695,513...61,748,259
|
|
G |
HLA-DRA |
major histocompatibility complex, class II, DR alpha |
decreases expression |
EXP |
chrysin results in decreased expression of HLA-DRA mRNA |
CTD |
PMID:20816778 |
|
NCBI chr 6:32,439,887...32,445,046
Ensembl chr 6:32,439,878...32,445,046
|
|
G |
HMOX1 |
heme oxygenase 1 |
multiple interactions decreases expression increases expression |
ISO EXP |
[chrysin results in increased expression of HMOX1 mRNA] which results in decreased susceptibility to tert-Butylhydroperoxide; [zinc protoporphyrin results in decreased activity of HMOX1 protein] inhibits the reaction [chrysin inhibits the reaction [tert-Butylhydroperoxide results in increased chemical synthesis of Reactive Oxygen Species]]; chrysin inhibits the reaction [Isoniazid results in increased expression of HMOX1 mRNA]; MAPK1 protein affects the reaction [chrysin results in increased expression of HMOX1 protein]; NFE2L2 protein affects the reaction [chrysin results in increased expression of HMOX1 protein] chrysin results in decreased expression of HMOX1 mRNA; chrysin results in decreased expression of HMOX1 protein chrysin results in increased expression of HMOX1 mRNA; chrysin results in increased expression of HMOX1 protein |
CTD |
PMID:22864849 PMID:23994249 PMID:33121995 |
|
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
|
|
G |
HNF4A |
hepatocyte nuclear factor 4 alpha |
multiple interactions |
EXP ISO |
chrysin inhibits the reaction [Hydrogen Peroxide results in decreased expression of HNF4A mRNA]; chrysin inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of HNF4A protein] chrysin inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased phosphorylation of and affects the localization of HNF4A protein] |
CTD |
PMID:32220030 |
|
NCBI chr20:44,355,699...44,434,596
Ensembl chr20:44,355,699...44,432,845
|
|
G |
ICAM1 |
intercellular adhesion molecule 1 |
multiple interactions |
EXP |
chrysin inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]; chrysin inhibits the reaction [TNF protein results in increased expression of ICAM1 protein] |
CTD |
PMID:15322261 PMID:16987811 |
|
NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
|
|
G |
IFNG |
interferon gamma |
multiple interactions |
ISO |
chrysin inhibits the reaction [Diazinon results in decreased expression of IFNG mRNA]; chrysin inhibits the reaction [Diazinon results in decreased expression of IFNG protein]; chrysin inhibits the reaction [Oxidopamine results in increased expression of IFNG protein] |
CTD |
PMID:29054324 PMID:36114367 |
|
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
|
|
G |
IGF1 |
insulin like growth factor 1 |
multiple interactions |
ISO |
chrysin inhibits the reaction [Testosterone results in increased expression of IGF1 mRNA] |
CTD |
PMID:29247772 |
|
NCBI chr12:102,395,874...102,481,839
Ensembl chr12:102,395,874...102,481,744
|
|
G |
IGF1R |
insulin like growth factor 1 receptor |
multiple interactions |
ISO |
chrysin inhibits the reaction [Testosterone results in increased expression of IGF1R mRNA] |
CTD |
PMID:29247772 |
|
NCBI chr15:98,648,539...98,964,530
Ensembl chr15:98,648,539...98,964,530
|
|
G |
IKBKB |
inhibitor of nuclear factor kappa B kinase subunit beta |
multiple interactions |
EXP |
chrysin inhibits the reaction [nickel chloride results in increased phosphorylation of IKBKB protein] |
CTD |
PMID:30016632 |
|
NCBI chr 8:42,271,302...42,332,460
Ensembl chr 8:42,271,302...42,332,460
|
|
G |
IL10 |
interleukin 10 |
multiple interactions |
ISO EXP |
chrysin inhibits the reaction [Cyclophosphamide results in increased expression of IL10 protein]; chrysin inhibits the reaction [Freund's Adjuvant results in decreased expression of IL10 protein] chrysin inhibits the reaction [nickel chloride results in increased expression of IL10 protein] chrysin inhibits the reaction [Diazinon results in increased expression of IL10 mRNA]; chrysin inhibits the reaction [Oxidopamine results in decreased expression of IL10 protein] |
CTD |
PMID:24932515 PMID:29054324 PMID:30016632 PMID:36114367 PMID:37263553 |
|
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
|
|
G |
IL15 |
interleukin 15 |
decreases expression |
EXP |
chrysin results in decreased expression of IL15 mRNA |
CTD |
PMID:20816778 |
|
NCBI chr 4:141,636,583...141,733,987
Ensembl chr 4:141,636,583...141,733,987
|
|
G |
IL17A |
interleukin 17A |
multiple interactions |
ISO |
chrysin inhibits the reaction [Diazinon results in increased expression of IL17A mRNA] |
CTD |
PMID:36114367 |
|
NCBI chr 6:52,186,375...52,190,638
Ensembl chr 6:52,186,375...52,190,638
|
|
G |
IL1B |
interleukin 1 beta |
multiple interactions decreases expression |
EXP ISO |
chrysin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL1B mRNA]; chrysin inhibits the reaction [IL1B protein results in increased phosphorylation of NFKBIA protein]; chrysin inhibits the reaction [IL1B protein results in increased secretion of CXCL8 protein]; chrysin inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; chrysin inhibits the reaction [nickel chloride results in increased expression of IL1B protein] chrysin inhibits the reaction [Oxidopamine results in increased expression of IL1B protein] chrysin inhibits the reaction [Acetaminophen results in increased expression of IL1B protein]; chrysin inhibits the reaction [Cyclophosphamide results in increased expression of IL1B protein]; chrysin inhibits the reaction [Isoniazid results in increased expression of IL1B mRNA] chrysin results in decreased expression of IL1B mRNA |
CTD |
PMID:18377686 PMID:20816778 PMID:21515303 PMID:28682524 PMID:29054324 PMID:30016632 PMID:33121995 PMID:34774662 PMID:37263553 More...
|
|
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
IL1R1 |
interleukin 1 receptor type 1 |
decreases expression |
EXP |
chrysin results in decreased expression of IL1R1 mRNA |
CTD |
PMID:20816778 |
|
NCBI chr 2:102,070,390...102,179,874
Ensembl chr 2:102,064,544...102,179,874
|
|
G |
IL4 |
interleukin 4 |
multiple interactions |
EXP ISO |
chrysin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL4 mRNA] chrysin inhibits the reaction [Diazinon results in increased expression of IL4 mRNA] |
CTD |
PMID:21515303 PMID:36114367 |
|
NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
|
|
G |
IL6 |
interleukin 6 |
multiple interactions increases expression decreases expression |
EXP ISO |
chrysin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL6 mRNA]; chrysin inhibits the reaction [nickel chloride results in increased expression of IL6 protein] chrysin inhibits the reaction [Oxidopamine results in increased expression of IL6 protein] chrysin inhibits the reaction [[Diethylnitrosamine co-treated with ferric nitrilotriacetate] results in increased expression of IL6 protein]; chrysin inhibits the reaction [Cyclophosphamide results in increased expression of IL6 protein]; chrysin inhibits the reaction [Isoniazid results in increased expression of IL6 mRNA]; chrysin inhibits the reaction [Thioacetamide results in increased expression of IL6 protein] chrysin results in increased expression of IL6 mRNA chrysin results in decreased expression of IL6 mRNA |
CTD |
PMID:18457675 PMID:20816778 PMID:21515303 PMID:23194824 PMID:29054324 PMID:30016632 PMID:30500344 PMID:33121995 PMID:37263553 More...
|
|
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
INS-IGF2 |
INS-IGF2 readthrough |
multiple interactions |
ISO |
2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [chrysin inhibits the reaction [Fructose results in increased expression of INS1 protein]]; chrysin inhibits the reaction [Fructose results in increased expression of INS1 protein] |
CTD |
PMID:25169908 |
|
NCBI chr11:2,129,117...2,161,209
Ensembl chr11:2,132,538...2,161,209
|
|
G |
IRF3 |
interferon regulatory factor 3 |
multiple interactions |
ISO |
chrysin inhibits the reaction [Poly I-C results in increased expression of IRF3 mRNA] |
CTD |
PMID:19426678 |
|
NCBI chr19:49,659,572...49,665,857
Ensembl chr19:49,659,569...49,665,875
|
|
G |
JUN |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions decreases phosphorylation |
EXP |
chrysin inhibits the reaction [TNF protein results in increased activity of [FOS protein binds to JUN protein]]; chrysin inhibits the reaction [TNF protein results in increased expression of JUN mRNA] chrysin results in decreased phosphorylation of JUN protein |
CTD |
PMID:15322261 PMID:30578657 |
|
NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048
|
|
G |
KLF4 |
KLF transcription factor 4 |
multiple interactions |
EXP |
chrysin inhibits the reaction [angiotensin II increases expression of KLF4 protein in vascular smooth muscle cells] |
RGD |
PMID:29127880 |
RGD:155230825 |
NCBI chr 9:107,484,852...107,489,769
Ensembl chr 9:107,484,852...107,490,482
|
|
G |
LAMB2 |
laminin subunit beta 2 |
increases expression |
EXP |
chrysin results in increased expression of LAMB2 protein |
CTD |
PMID:26408079 |
|
NCBI chr 3:49,121,114...49,133,050
Ensembl chr 3:49,121,114...49,133,118
|
|
G |
LEP |
leptin |
decreases expression |
ISO |
chrysin results in decreased expression of LEP protein |
CTD |
PMID:30445784 |
|
NCBI chr 7:128,241,278...128,257,629
Ensembl chr 7:128,241,278...128,257,629
|
|
G |
LHB |
luteinizing hormone subunit beta |
multiple interactions |
ISO |
chrysin inhibits the reaction [Freund's Adjuvant results in increased expression of LHB protein] |
CTD |
PMID:24932515 |
|
NCBI chr19:49,015,980...49,019,498
Ensembl chr19:49,015,980...49,017,091
|
|
G |
MAP1LC3B |
microtubule associated protein 1 light chain 3 beta |
multiple interactions |
ISO |
chrysin inhibits the reaction [Acetaminophen results in increased expression of MAP1LC3B protein]; chrysin inhibits the reaction [Colistin results in increased expression of MAP1LC3B protein] |
CTD |
PMID:28682524 PMID:30273961 |
|
NCBI chr16:87,392,336...87,404,774
Ensembl chr16:87,383,953...87,404,779
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
multiple interactions increases phosphorylation increases activity |
ISO EXP |
MAPK1 protein affects the reaction [chrysin results in increased expression of GCLC protein]; MAPK1 protein affects the reaction [chrysin results in increased expression of GCLM protein]; MAPK1 protein affects the reaction [chrysin results in increased expression of HMOX1 protein] [chrysin co-treated with Cisplatin] results in increased phosphorylation of MAPK1 protein chrysin results in increased phosphorylation of MAPK1 protein chrysin results in increased activity of MAPK1 protein |
CTD |
PMID:22864849 PMID:25770930 |
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
|
|
G |
MAPK14 |
mitogen-activated protein kinase 14 |
multiple interactions |
ISO |
chrysin inhibits the reaction [Cyclophosphamide results in increased expression of MAPK14 protein] |
CTD |
PMID:37263553 |
|
NCBI chr 6:36,027,808...36,124,214
Ensembl chr 6:36,027,782...36,111,236
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
multiple interactions increases phosphorylation |
EXP |
[chrysin co-treated with Cisplatin] results in increased phosphorylation of MAPK3 protein chrysin results in increased phosphorylation of MAPK3 protein |
CTD |
PMID:25770930 |
|
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
|
|
G |
MMP1 |
matrix metallopeptidase 1 |
decreases expression |
EXP |
chrysin results in decreased expression of MMP1 protein |
CTD |
PMID:30578657 |
|
NCBI chr11:102,789,919...102,798,160
Ensembl chr11:102,789,401...102,798,160
|
|
G |
MMP10 |
matrix metallopeptidase 10 |
multiple interactions decreases expression |
EXP |
chrysin inhibits the reaction [AKT1 protein results in increased expression of MMP10 protein] chrysin results in decreased expression of MMP10 protein |
CTD |
PMID:24122885 |
|
NCBI chr11:102,770,502...102,780,628
Ensembl chr11:102,770,502...102,780,628
|
|
G |
MMP2 |
matrix metallopeptidase 2 |
multiple interactions decreases activity |
EXP |
chrysin results in decreased expression of and results in decreased activity of MMP2 protein chrysin results in decreased activity of MMP2 protein |
CTD |
PMID:26408079 PMID:30578657 |
|
NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691
|
|
G |
MMP9 |
matrix metallopeptidase 9 |
multiple interactions |
EXP |
chrysin inhibits the reaction [nickel chloride results in increased expression of and results in increased activity of MMP9 protein] |
CTD |
PMID:30016632 |
|
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
|
|
G |
MPO |
myeloperoxidase |
multiple interactions |
ISO |
chrysin inhibits the reaction [Freund's Adjuvant results in increased activity of MPO protein] |
CTD |
PMID:24932515 |
|
NCBI chr17:58,269,855...58,280,935
Ensembl chr17:58,269,855...58,280,935
|
|
G |
MYBL1 |
MYB proto-oncogene like 1 |
increases expression multiple interactions |
EXP |
chrysin results in increased expression of MYBL1 mRNA Fulvestrant inhibits the reaction [chrysin results in increased expression of MYBL1 mRNA] |
CTD |
PMID:33405908 |
|
NCBI chr 8:66,562,175...66,613,218
Ensembl chr 8:66,562,175...66,614,247
|
|
G |
MYD88 |
MYD88 innate immune signal transduction adaptor |
multiple interactions |
EXP |
chrysin inhibits the reaction [nickel chloride results in increased expression of MYD88 mRNA]; chrysin inhibits the reaction [nickel chloride results in increased expression of MYD88 protein] |
CTD |
PMID:30016632 |
|
NCBI chr 3:38,138,661...38,143,022
Ensembl chr 3:38,138,552...38,143,024
|
|
G |
NFE2L2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions decreases expression |
ISO EXP |
chrysin affects the localization of and results in increased activity of NFE2L2 protein; chrysin inhibits the reaction [Isoniazid results in increased expression of NFE2L2 mRNA]; NFE2L2 protein affects the reaction [chrysin results in increased expression of GCLC protein]; NFE2L2 protein affects the reaction [chrysin results in increased expression of GCLM protein]; NFE2L2 protein affects the reaction [chrysin results in increased expression of HMOX1 protein] chrysin inhibits the reaction [NFE2L2 protein results in decreased susceptibility to Doxorubicin] chrysin results in decreased expression of NFE2L2 mRNA; chrysin results in decreased expression of NFE2L2 protein |
CTD |
PMID:22864849 PMID:23994249 PMID:33121995 |
|
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
|
|
G |
NFKB1 |
nuclear factor kappa B subunit 1 |
multiple interactions |
ISO |
chrysin inhibits the reaction [Isoniazid results in increased expression of NFKB1 mRNA]; chrysin inhibits the reaction [Thioacetamide results in increased expression of NFKB1 protein] |
CTD |
PMID:30500344 PMID:33121995 |
|
NCBI chr 4:102,501,359...102,617,302
Ensembl chr 4:102,501,330...102,617,302
|
|
G |
NFKBIA |
NFKB inhibitor alpha |
multiple interactions decreases expression |
EXP |
chrysin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased degradation of NFKBIA protein]; chrysin inhibits the reaction [IL1B protein results in increased phosphorylation of NFKBIA protein]; chrysin inhibits the reaction [nickel chloride results in increased phosphorylation of NFKBIA protein] chrysin results in decreased expression of NFKBIA protein |
CTD |
PMID:18377686 PMID:21515303 PMID:30016632 PMID:30578657 |
|
NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749
|
|
G |
NGF |
nerve growth factor |
multiple interactions |
ISO |
chrysin inhibits the reaction [Oxidopamine results in decreased expression of NGF protein] |
CTD |
PMID:29054324 |
|
NCBI chr 1:115,285,917...115,338,249
Ensembl chr 1:115,285,904...115,338,770
|
|
G |
NOS2 |
nitric oxide synthase 2 |
multiple interactions |
ISO EXP |
chrysin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; chrysin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]; PPARG protein affects the reaction [chrysin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]] chrysin inhibits the reaction [[Diethylnitrosamine co-treated with ferric nitrilotriacetate] results in increased expression of NOS2 protein]; chrysin inhibits the reaction [Cyclophosphamide results in increased expression of NOS2 protein]; chrysin inhibits the reaction [ferric nitrilotriacetate results in increased expression of NOS2 protein]; chrysin inhibits the reaction [Freund's Adjuvant results in increased expression of NOS2 protein] |
CTD |
PMID:11343698 PMID:16934226 PMID:17570322 PMID:23194824 PMID:24932515 PMID:34774662 PMID:37263553 More...
|
|
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|
G |
NOS3 |
nitric oxide synthase 3 |
multiple interactions |
ISO |
chrysin inhibits the reaction [alpha-naphthyl thiourea results in decreased expression of NOS3 mRNA] |
CTD |
PMID:30974023 |
|
NCBI chr 7:150,991,017...151,014,588
Ensembl chr 7:150,991,017...151,014,588
|
|
G |
NQO1 |
NAD(P)H quinone dehydrogenase 1 |
multiple interactions |
ISO |
chrysin inhibits the reaction [Isoniazid results in increased expression of NQO1 mRNA] |
CTD |
PMID:33121995 |
|
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
|
|
G |
NR1H3 |
nuclear receptor subfamily 1 group H member 3 |
increases expression |
ISO |
Chrysin increases expression of Nr1h3 mRNA in macrophages |
RGD |
PMID:25857322 |
RGD:401850558 |
NCBI chr11:47,248,300...47,269,033
Ensembl chr11:47,248,300...47,269,033
|
|
G |
NR1H4 |
nuclear receptor subfamily 1 group H member 4 |
multiple interactions |
EXP |
chrysin inhibits the reaction [pregna-4,17-diene-3,16-dione results in decreased activity of NR1H4 protein] |
CTD |
PMID:25257666 |
|
NCBI chr12:100,473,866...100,564,414
Ensembl chr12:100,473,708...100,564,414
|
|
G |
NR1I2 |
nuclear receptor subfamily 1 group I member 2 |
multiple interactions |
ISO EXP |
chrysin binds to and results in increased activity of NR1I2 protein |
CTD |
PMID:33049310 |
|
NCBI chr 3:119,782,101...119,818,487
Ensembl chr 3:119,780,484...119,818,487
|
|
G |
NR1I3 |
nuclear receptor subfamily 1 group I member 3 |
affects localization multiple interactions |
EXP ISO |
chrysin affects the localization of NR1I3 protein NR1I3 gene mutant form inhibits the reaction [chrysin results in increased expression of CYP2B10 mRNA] |
CTD |
PMID:25625231 |
|
NCBI chr 1:161,229,669...161,238,203
Ensembl chr 1:161,229,666...161,238,244
|
|
G |
PARP1 |
poly(ADP-ribose) polymerase 1 |
increases cleavage multiple interactions |
EXP ISO |
chrysin results in increased cleavage of PARP1 protein chrysin inhibits the reaction [Cyclophosphamide results in increased expression of PARP1 protein] [Cisplatin co-treated with chrysin] results in increased cleavage of PARP1 protein; benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[Cisplatin co-treated with chrysin] results in increased cleavage of PARP1 protein] |
CTD |
PMID:18455702 PMID:25770930 PMID:37263553 |
|
NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
|
|
G |
PCNA |
proliferating cell nuclear antigen |
multiple interactions |
ISO |
chrysin inhibits the reaction [[Diethylnitrosamine co-treated with ferric nitrilotriacetate] results in increased expression of PCNA protein]; chrysin inhibits the reaction [Testosterone results in increased expression of PCNA protein] |
CTD |
PMID:23194824 PMID:29247772 |
|
NCBI chr20:5,114,953...5,126,622
Ensembl chr20:5,114,953...5,126,626
|
|
G |
PGD |
phosphogluconate dehydrogenase |
decreases activity |
EXP |
chrysin results in decreased activity of PGD protein |
CTD |
PMID:25130191 |
|
NCBI chr 1:10,399,064...10,420,511
Ensembl chr 1:10,398,592...10,420,511
|
|
G |
PLAU |
plasminogen activator, urokinase |
decreases expression |
EXP |
chrysin results in decreased expression of PLAU protein |
CTD |
PMID:30578657 |
|
NCBI chr10:73,909,164...73,917,494
Ensembl chr10:73,909,177...73,917,496
|
|
G |
PLCG1 |
phospholipase C gamma 1 |
multiple interactions increases degradation |
EXP |
BCL2 protein inhibits the reaction [chrysin results in increased degradation of PLCG1 protein] |
CTD |
PMID:16215670 |
|
NCBI chr20:41,137,543...41,177,626
Ensembl chr20:41,136,960...41,196,801
|
|
G |
POR |
cytochrome p450 oxidoreductase |
multiple interactions |
EXP |
[CYP2A6 protein co-treated with POR protein] results in increased oxidation of chrysin |
CTD |
PMID:30964977 |
|
NCBI chr 7:75,915,155...75,986,855
Ensembl chr 7:75,899,200...75,986,855
|
|
G |
PPARA |
peroxisome proliferator activated receptor alpha |
decreases expression |
EXP |
chrysin results in decreased expression of PPARA mRNA |
CTD |
PMID:20816778 |
|
NCBI chr22:46,150,526...46,243,756
Ensembl chr22:46,150,521...46,243,755
|
|
G |
PPARG |
peroxisome proliferator activated receptor gamma |
multiple interactions |
ISO EXP |
chrysin binds to and results in increased activity of PPARG protein; PPARG protein affects the reaction [chrysin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]]; PPARG protein affects the reaction [chrysin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]] |
CTD |
PMID:11343698 PMID:33049310 |
|
NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356
|
|
G |
PSCA |
prostate stem cell antigen |
decreases expression |
EXP |
chrysin results in decreased expression of PSCA mRNA |
CTD |
PMID:18331776 |
|
NCBI chr 8:142,670,297...142,682,725
Ensembl chr 8:142,670,308...142,682,725
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
increases expression multiple interactions |
EXP ISO |
chrysin results in increased expression of PTGS2 mRNA chrysin inhibits the reaction [[Diethylnitrosamine co-treated with ferric nitrilotriacetate] results in increased expression of PTGS2 protein]; chrysin inhibits the reaction [Diethylnitrosamine results in increased expression of PTGS2 mRNA]; chrysin inhibits the reaction [ferric nitrilotriacetate results in increased expression of PTGS2 protein]; chrysin inhibits the reaction [Freund's Adjuvant results in increased expression of PTGS2 protein] chrysin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; PPARG protein affects the reaction [chrysin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]] |
CTD |
PMID:11343698 PMID:18457675 PMID:21167192 PMID:23194824 PMID:24932515 |
|
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
|
|
G |
PTK2 |
protein tyrosine kinase 2 |
decreases phosphorylation |
EXP |
chrysin results in decreased phosphorylation of PTK2 protein |
CTD |
PMID:30578657 |
|
NCBI chr 8:140,657,900...141,002,079
Ensembl chr 8:140,657,900...141,002,216
|
|
G |
RBP4 |
retinol binding protein 4 |
decreases expression |
ISO |
chrysin results in decreased expression of RBP4 protein |
CTD |
PMID:30445784 |
|
NCBI chr10:93,591,694...93,601,744
Ensembl chr10:93,591,687...93,601,744
|
|
G |
RELA |
RELA proto-oncogene, NF-kB subunit |
multiple interactions decreases expression increases activity |
EXP ISO |
Acetylcysteine inhibits the reaction [chrysin results in increased activity of RELA protein]; chrysin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] affects the localization of RELA protein]; chrysin inhibits the reaction [nickel chloride affects the localization of RELA protein]; SB 203580 inhibits the reaction [chrysin results in increased activity of RELA protein] chrysin results in decreased expression of RELA protein chrysin inhibits the reaction [Oxidopamine results in increased phosphorylation of RELA protein] chrysin inhibits the reaction [[Diethylnitrosamine co-treated with ferric nitrilotriacetate] results in increased localization of RELA protein]; chrysin inhibits the reaction [Diethylnitrosamine results in increased expression of RELA mRNA]; chrysin inhibits the reaction [Diethylnitrosamine results in increased expression of RELA protein]; chrysin inhibits the reaction [Testosterone results in increased activity of RELA protein] |
CTD |
PMID:18457675 PMID:21167192 PMID:21515303 PMID:23194824 PMID:29054324 PMID:29247772 PMID:30016632 PMID:30578657 More...
|
|
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
|
|
G |
RHOA |
ras homolog family member A |
decreases expression |
EXP |
chrysin results in decreased expression of RHOA protein |
CTD |
PMID:30578657 |
|
NCBI chr 3:49,359,145...49,411,976
Ensembl chr 3:49,359,139...49,412,998
|
|
G |
RORC |
RAR related orphan receptor C |
multiple interactions |
ISO |
chrysin inhibits the reaction [Diazinon results in increased expression of RORC mRNA] |
CTD |
PMID:36114367 |
|
NCBI chr 1:151,806,071...151,831,802
Ensembl chr 1:151,806,071...151,831,845
|
|
G |
S100B |
S100 calcium binding protein B |
multiple interactions |
ISO |
chrysin inhibits the reaction [Oxidopamine results in increased expression of S100B protein] |
CTD |
PMID:29054324 |
|
NCBI chr21:46,598,604...46,605,082
Ensembl chr21:46,598,604...46,605,208
|
|
G |
SC5D |
sterol-C5-desaturase |
decreases expression |
EXP |
chrysin results in decreased expression of SC5D mRNA |
CTD |
PMID:20816778 |
|
NCBI chr11:121,292,771...121,313,410
Ensembl chr11:121,292,681...121,313,410
|
|
G |
SCD |
stearoyl-CoA desaturase |
decreases expression |
EXP |
chrysin results in decreased expression of SCD mRNA |
CTD |
PMID:20816778 |
|
NCBI chr10:100,347,233...100,364,826
Ensembl chr10:100,347,233...100,364,826
|
|
G |
SELE |
selectin E |
multiple interactions |
EXP |
chrysin inhibits the reaction [TNF protein results in increased expression of SELE protein] |
CTD |
PMID:16987811 |
|
NCBI chr 1:169,722,640...169,734,079
Ensembl chr 1:169,722,640...169,764,705
|
|
G |
SFN |
stratifin |
increases expression |
EXP |
chrysin results in increased expression of SFN mRNA; chrysin results in increased expression of SFN protein |
CTD |
PMID:18331776 |
|
NCBI chr 1:26,863,149...26,864,456
Ensembl chr 1:26,863,149...26,864,456
|
|
G |
SGK1 |
serum/glucocorticoid regulated kinase 1 |
increases expression multiple interactions |
EXP |
chrysin results in increased expression of SGK1 mRNA Fulvestrant inhibits the reaction [chrysin results in increased expression of SGK1 mRNA] |
CTD |
PMID:33405908 |
|
NCBI chr 6:134,169,256...134,318,112
Ensembl chr 6:134,169,248...134,318,112
|
|
G |
SHBG |
sex hormone binding globulin |
affects binding |
EXP |
chrysin binds to SHBG protein |
CTD |
PMID:25349334 |
|
NCBI chr17:7,614,064...7,633,372
Ensembl chr17:7,613,946...7,633,382
|
|
G |
SLC16A1 |
solute carrier family 16 member 1 |
multiple interactions |
ISO |
[chrysin results in decreased activity of SLC16A1 protein] which results in decreased uptake of Sodium Oxybate |
CTD |
PMID:17108059 |
|
NCBI chr 1:112,911,847...112,956,196
Ensembl chr 1:112,911,847...112,957,593
|
|
G |
SMAD2 |
SMAD family member 2 |
multiple interactions |
ISO |
chrysin inhibits the reaction [Carbon Tetrachloride results in increased expression of SMAD2 mRNA] |
CTD |
PMID:26297989 |
|
NCBI chr18:47,808,957...47,930,872
Ensembl chr18:47,808,957...47,931,146
|
|
G |
SMAD3 |
SMAD family member 3 |
multiple interactions |
ISO |
chrysin inhibits the reaction [Carbon Tetrachloride results in increased expression of SMAD3 mRNA] |
CTD |
PMID:26297989 |
|
NCBI chr15:67,065,602...67,195,169
Ensembl chr15:67,063,763...67,195,173
|
|
G |
SNAI1 |
snail family transcriptional repressor 1 |
decreases expression multiple interactions |
EXP |
chrysin results in decreased expression of SNAI1 protein chrysin inhibits the reaction [AKT1 protein results in increased expression of SNAI1 protein] |
CTD |
PMID:24122885 PMID:30578657 |
|
NCBI chr20:49,982,980...49,988,886
Ensembl chr20:49,982,980...49,988,886
|
|
G |
SNAI2 |
snail family transcriptional repressor 2 |
decreases expression |
EXP |
chrysin results in decreased expression of SNAI2 protein |
CTD |
PMID:24122885 |
|
NCBI chr 8:48,917,598...48,921,429
Ensembl chr 8:48,917,598...48,921,740
|
|
G |
SOS1 |
SOS Ras/Rac guanine nucleotide exchange factor 1 |
decreases expression |
EXP |
chrysin results in decreased expression of SOS1 protein |
CTD |
PMID:30578657 |
|
NCBI chr 2:38,981,549...39,124,868
Ensembl chr 2:38,962,206...39,124,345
|
|
G |
STAR |
steroidogenic acute regulatory protein |
multiple interactions |
ISO |
chrysin inhibits the reaction [Freund's Adjuvant results in decreased expression of STAR mRNA] |
CTD |
PMID:24932515 |
|
NCBI chr 8:38,142,700...38,150,952
Ensembl chr 8:38,142,700...38,150,992
|
|
G |
STAT3 |
signal transducer and activator of transcription 3 |
multiple interactions |
ISO |
chrysin inhibits the reaction [Cyclophosphamide results in increased phosphorylation of STAT3 protein] |
CTD |
PMID:37263553 |
|
NCBI chr17:42,313,324...42,388,442
Ensembl chr17:42,313,324...42,388,568
|
|
G |
SULT1A1 |
sulfotransferase family 1A member 1 |
increases sulfation |
EXP |
SULT1A1 protein SNP results in increased sulfation of chrysin |
CTD |
PMID:17293380 |
|
NCBI chr16:28,605,258...28,623,375
Ensembl chr16:28,605,196...28,610,044
|
|
G |
SULT1E1 |
sulfotransferase family 1E member 1 |
multiple interactions |
EXP |
SULT1E1 protein results in increased sulfation of and results in decreased activity of chrysin |
CTD |
PMID:17293380 |
|
NCBI chr 4:69,821,122...69,860,145
Ensembl chr 4:69,841,212...69,860,145
|
|
G |
TBK1 |
TANK binding kinase 1 |
decreases activity |
EXP |
chrysin results in decreased activity of TBK1 protein |
CTD |
PMID:19426678 |
|
NCBI chr12:64,452,120...64,502,114
Ensembl chr12:64,452,090...64,502,114
|
|
G |
TBX21 |
T-box transcription factor 21 |
multiple interactions |
ISO |
chrysin inhibits the reaction [Diazinon results in decreased expression of TBX21 mRNA] |
CTD |
PMID:36114367 |
|
NCBI chr17:47,733,236...47,746,122
Ensembl chr17:47,733,236...47,746,122
|
|
G |
TFF1 |
trefoil factor 1 |
multiple interactions |
EXP |
chrysin promotes the reaction [ESR1 protein binds to TFF1 promoter] |
CTD |
PMID:16972788 |
|
NCBI chr21:42,362,282...42,366,535
Ensembl chr21:42,362,282...42,366,535
|
|
G |
TGFB1 |
transforming growth factor beta 1 |
multiple interactions |
ISO |
chrysin inhibits the reaction [Carbon Tetrachloride results in increased expression of TGFB1 mRNA]; chrysin inhibits the reaction [Diazinon results in increased expression of TGFB1 mRNA] |
CTD |
PMID:26297989 PMID:36114367 |
|
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
|
|
G |
THRA |
thyroid hormone receptor alpha |
multiple interactions |
EXP |
chrysin binds to and results in increased activity of THRA protein |
CTD |
PMID:33049310 |
|
NCBI chr17:40,062,193...40,093,867
Ensembl chr17:40,058,290...40,093,867
|
|
G |
THRB |
thyroid hormone receptor beta |
multiple interactions |
EXP |
chrysin binds to and results in increased activity of THRB protein |
CTD |
PMID:33049310 |
|
NCBI chr 3:24,117,153...24,495,708
Ensembl chr 3:24,117,153...24,495,756
|
|
G |
TLR4 |
toll like receptor 4 |
multiple interactions |
EXP ISO |
chrysin inhibits the reaction [nickel chloride results in increased expression of TLR4 mRNA]; chrysin inhibits the reaction [nickel chloride results in increased expression of TLR4 protein] chrysin inhibits the reaction [Thioacetamide results in increased expression of TLR4 mRNA] |
CTD |
PMID:30016632 PMID:30500344 |
|
NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions decreases expression |
EXP ISO |
chrysin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of TNF mRNA]; chrysin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of TNF protein]; chrysin inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; chrysin inhibits the reaction [nickel chloride results in increased expression of TNF protein]; chrysin inhibits the reaction [TNF protein results in increased activity of [FOS protein binds to JUN protein]]; chrysin inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]; chrysin inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]; chrysin inhibits the reaction [TNF protein results in increased expression of JUN mRNA]; chrysin inhibits the reaction [TNF protein results in increased expression of SELE protein]; chrysin inhibits the reaction [TNF protein results in increased expression of VCAM1 protein] chrysin results in decreased expression of TNF protein chrysin inhibits the reaction [[Diethylnitrosamine co-treated with ferric nitrilotriacetate] results in increased expression of TNF protein]; chrysin inhibits the reaction [Acetaminophen results in increased expression of TNF protein]; chrysin inhibits the reaction [Cyclophosphamide results in increased expression of TNF protein]; chrysin inhibits the reaction [Freund's Adjuvant results in increased expression of TNF protein]; chrysin inhibits the reaction [Isoniazid results in increased expression of TNF protein]; chrysin inhibits the reaction [Thioacetamide results in increased expression of TNF protein]; Silymarin promotes the reaction [chrysin inhibits the reaction [Acetaminophen results in increased expression of TNF protein]] chrysin inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]; chrysin inhibits the reaction [Oxidopamine results in increased expression of TNF protein] |
CTD |
PMID:15322261 PMID:16934226 PMID:16987811 PMID:21515303 PMID:23194824 PMID:24932515 PMID:28682524 PMID:29054324 PMID:30016632 PMID:30445784 PMID:30500344 PMID:31625388 PMID:33121995 PMID:34774662 PMID:37263553 More...
|
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
TNFRSF10B |
TNF receptor superfamily member 10b |
multiple interactions |
EXP |
[Cisplatin co-treated with chrysin] results in increased expression of TNFRSF10B protein |
CTD |
PMID:25770930 |
|
NCBI chr 8:23,020,133...23,069,031
Ensembl chr 8:23,020,133...23,069,031
|
|
G |
TNFSF10 |
TNF superfamily member 10 |
multiple interactions increases response to substance |
EXP |
chrysin promotes the reaction [TNFSF10 protein results in increased degradation of CASP3 protein]; chrysin promotes the reaction [TNFSF10 protein results in increased degradation of CASP8 protein] chrysin results in increased susceptibility to TNFSF10 protein |
CTD |
PMID:21195158 |
|
NCBI chr 3:172,505,508...172,523,430
Ensembl chr 3:172,505,508...172,523,475
|
|
G |
TP53 |
tumor protein p53 |
increases degradation affects activity multiple interactions |
EXP ISO |
chrysin results in increased degradation of TP53 protein chrysin affects the activity of TP53 protein [Cisplatin co-treated with chrysin] affects the localization of TP53 protein; [Cisplatin co-treated with chrysin] results in increased phosphorylation of and results in increased expression of TP53 protein; chrysin results in increased phosphorylation of and affects the localization of TP53 protein; U 0126 inhibits the reaction [[Cisplatin co-treated with chrysin] affects the localization of TP53 protein]; U 0126 inhibits the reaction [[Cisplatin co-treated with chrysin] results in increased phosphorylation of TP53 protein] [Diethylnitrosamine co-treated with chrysin] results in increased expression of TP53 protein; chrysin inhibits the reaction [Diethylnitrosamine results in decreased expression of TP53 mRNA]; chrysin inhibits the reaction [Testosterone results in decreased expression of TP53 mRNA] |
CTD |
PMID:14634213 PMID:21167192 PMID:25770930 PMID:29247772 PMID:35435491 |
|
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538
|
|
G |
TP53I3 |
tumor protein p53 inducible protein 3 |
increases expression |
EXP |
chrysin results in increased expression of TP53I3 mRNA; chrysin results in increased expression of TP53I3 protein |
CTD |
PMID:18331776 PMID:19397994 |
|
NCBI chr 2:24,077,433...24,084,834
Ensembl chr 2:24,077,433...24,085,861
|
|
G |
TP63 |
tumor protein p63 |
increases expression |
EXP |
chrysin results in increased expression of TP63 protein |
CTD |
PMID:18331776 PMID:19397994 |
|
NCBI chr 3:189,596,746...189,897,276
Ensembl chr 3:189,631,389...189,897,276
|
|
G |
TP73 |
tumor protein p73 |
increases expression |
EXP |
chrysin results in increased expression of TP73 protein |
CTD |
PMID:18331776 PMID:19397994 |
|
NCBI chr 1:3,652,516...3,736,201
Ensembl chr 1:3,652,516...3,736,201
|
|
G |
TYR |
tyrosinase |
increases expression |
ISO |
chrysin results in increased expression of TYR mRNA |
CTD |
PMID:21071833 |
|
NCBI chr11:89,177,875...89,295,759
Ensembl chr11:89,177,875...89,295,759
|
|
G |
UGT1A1 |
UDP glucuronosyltransferase family 1 member A1 |
multiple interactions affects glucuronidation increases glucuronidation increases expression |
EXP ISO |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [chrysin results in increased expression of UGT1A1 mRNA]; chrysin inhibits the reaction [AHR protein binds to UGT1A1 promoter]; chrysin promotes the reaction [UGT1A1 protein affects the glucuronidation of Bilirubin]; chrysin promotes the reaction [UGT1A1 protein affects the glucuronidation of Ethinyl Estradiol]; chrysin promotes the reaction [UGT1A1 protein results in increased glucuronidation of Bilirubin]; chrysin promotes the reaction [UGT1A1 protein results in increased glucuronidation of Quercetin]; pyrazolanthrone inhibits the reaction [chrysin results in increased expression of UGT1A1 mRNA]; SB 203580 inhibits the reaction [chrysin results in increased expression of UGT1A1 mRNA]; U 0126 inhibits the reaction [chrysin results in increased expression of UGT1A1 mRNA] UGT1A1 protein affects the glucuronidation of chrysin UGT1A1 protein results in increased glucuronidation of chrysin chrysin results in increased expression of UGT1A1; chrysin results in increased expression of UGT1A1 mRNA; chrysin results in increased expression of UGT1A1 protein |
CTD |
PMID:10950852 PMID:11442279 PMID:14557274 PMID:15104253 PMID:16003560 PMID:17256720 PMID:17599282 More...
|
|
NCBI chr 2:233,760,270...233,773,300
Ensembl chr 2:233,760,270...233,773,300
|
|
G |
UGT1A10 |
UDP glucuronosyltransferase family 1 member A10 |
increases glucuronidation |
EXP |
UGT1A10 protein results in increased glucuronidation of chrysin |
CTD |
PMID:14557274 |
|
NCBI chr 2:233,636,448...233,773,300
Ensembl chr 2:233,636,448...233,773,300
|
|
G |
UGT1A6 |
UDP glucuronosyltransferase family 1 member A6 |
affects glucuronidation |
EXP |
UGT1A6 protein affects the glucuronidation of chrysin |
CTD |
PMID:10950852 |
|
NCBI chr 2:233,691,702...233,773,300
Ensembl chr 2:233,691,607...233,773,300
|
|
G |
UGT1A7 |
UDP glucuronosyltransferase family 1 member A7 |
increases glucuronidation |
EXP |
UGT1A7 protein results in increased glucuronidation of chrysin |
CTD |
PMID:14557274 |
|
NCBI chr 2:233,681,901...233,773,300
Ensembl chr 2:233,681,901...233,773,300
|
|
G |
UGT1A8 |
UDP glucuronosyltransferase family 1 member A8 |
increases glucuronidation |
EXP |
UGT1A8 protein results in increased glucuronidation of chrysin |
CTD |
PMID:14557274 |
|
NCBI chr 2:233,617,633...233,773,300
Ensembl chr 2:233,617,633...233,773,300
|
|
G |
UGT1A9 |
UDP glucuronosyltransferase family 1 member A9 |
increases glucuronidation affects glucuronidation |
EXP |
UGT1A9 protein results in increased glucuronidation of chrysin UGT1A9 protein affects the glucuronidation of chrysin |
CTD |
PMID:10950852 PMID:14557274 |
|
NCBI chr 2:233,671,898...233,773,300
Ensembl chr 2:233,671,898...233,773,300
|
|
G |
UGT2B15 |
UDP glucuronosyltransferase family 2 member B15 |
increases metabolic processing |
EXP |
UGT2B15 protein results in increased metabolism of chrysin |
CTD |
PMID:7835232 |
|
NCBI chr 4:68,646,597...68,670,652
Ensembl chr 4:68,646,597...68,670,652
|
|
G |
UTRN |
utrophin |
increases expression |
EXP |
chrysin results in increased expression of UTRN mRNA |
CTD |
PMID:22028826 |
|
NCBI chr 6:144,285,335...144,853,034
Ensembl chr 6:144,285,335...144,853,034
|
|
G |
VCAM1 |
vascular cell adhesion molecule 1 |
increases expression multiple interactions |
EXP |
chrysin results in increased expression of VCAM1 mRNA chrysin inhibits the reaction [TNF protein results in increased expression of VCAM1 protein] |
CTD |
PMID:16987811 PMID:18457675 |
|
NCBI chr 1:100,719,742...100,739,045
Ensembl chr 1:100,719,742...100,739,045
|
|
G |
VEGFA |
vascular endothelial growth factor A |
decreases expression multiple interactions |
EXP ISO |
chrysin results in decreased expression of VEGFA protein chrysin inhibits the reaction [alpha-naphthyl thiourea results in increased expression of VEGFA mRNA] |
CTD |
PMID:30578657 PMID:30974023 |
|
NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
|
|
G |
VIM |
vimentin |
decreases expression |
EXP |
chrysin results in decreased expression of VIM protein |
CTD |
PMID:24122885 |
|
NCBI chr10:17,228,241...17,237,593
Ensembl chr10:17,228,241...17,237,593
|
|
G |
XIAP |
X-linked inhibitor of apoptosis |
decreases expression multiple interactions |
EXP |
chrysin results in decreased expression of XIAP protein BCL2 protein inhibits the reaction [chrysin results in decreased expression of XIAP protein] |
CTD |
PMID:16215670 |
|
NCBI chr X:123,859,708...123,913,972
Ensembl chr X:123,859,712...123,913,972
|
|
|
G |
ABCB1 |
ATP binding cassette subfamily B member 1 |
multiple interactions |
EXP |
5,7-dimethoxyflavone inhibits the reaction [ABCB1 protein results in decreased uptake of Daunorubicin]; 5,7-dimethoxyflavone inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]; 5,7-dimethoxyflavone inhibits the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]] |
CTD |
PMID:34217736 |
|
NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
multiple interactions |
ISO |
[5,7-dimethoxyflavone co-treated with Diethylnitrosamine] results in increased expression of BAX protein |
CTD |
PMID:21554863 |
|
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
|
|
G |
BCL2L1 |
BCL2 like 1 |
multiple interactions |
ISO |
5,7-dimethoxyflavone inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2L1 protein] |
CTD |
PMID:21554863 |
|
NCBI chr20:31,664,452...31,723,963
Ensembl chr20:31,664,452...31,723,989
|
|
G |
CASP3 |
caspase 3 |
multiple interactions |
ISO |
5,7-dimethoxyflavone promotes the reaction [Diethylnitrosamine results in increased expression of CASP3 protein] |
CTD |
PMID:21554863 |
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
CCL2 |
C-C motif chemokine ligand 2 |
multiple interactions |
EXP |
5,7-dimethoxyflavone inhibits the reaction [IL1B protein results in increased secretion of CCL2 protein] |
CTD |
PMID:24134915 |
|
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
|
|
G |
CCND1 |
cyclin D1 |
multiple interactions |
ISO |
5,7-dimethoxyflavone inhibits the reaction [Diethylnitrosamine results in increased expression of CCND1 mRNA]; 5,7-dimethoxyflavone inhibits the reaction [Diethylnitrosamine results in increased expression of CCND1 protein] |
CTD |
PMID:21554863 |
|
NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474
|
|
G |
CSNK2B |
casein kinase 2 beta |
multiple interactions |
ISO |
5,7-dimethoxyflavone inhibits the reaction [Diethylnitrosamine results in increased expression of CSNK2B mRNA]; 5,7-dimethoxyflavone inhibits the reaction [Diethylnitrosamine results in increased expression of CSNK2B protein] |
CTD |
PMID:21554863 |
|
NCBI chr 6:31,666,080...31,670,067
Ensembl chr 6:31,665,227...31,670,343
|
|
G |
CTNNB1 |
catenin beta 1 |
multiple interactions |
ISO |
5,7-dimethoxyflavone inhibits the reaction [Diethylnitrosamine affects the localization of CTNNB1 protein modified form]; 5,7-dimethoxyflavone inhibits the reaction [Diethylnitrosamine results in increased expression of CTNNB1 mRNA] |
CTD |
PMID:21554863 |
|
NCBI chr 3:41,199,505...41,240,443
Ensembl chr 3:41,194,741...41,260,096
|
|
G |
CXCL8 |
C-X-C motif chemokine ligand 8 |
multiple interactions |
EXP |
5,7-dimethoxyflavone inhibits the reaction [IL1B protein results in increased secretion of CXCL8 protein] |
CTD |
PMID:24134915 |
|
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
|
|
G |
CYP1A1 |
cytochrome P450 family 1 subfamily A member 1 |
multiple interactions decreases activity |
EXP |
5,7-dimethoxyflavone inhibits the reaction [Benzo(a)pyrene results in increased expression of and results in increased activity of CYP1A1 protein]; 5,7-dimethoxyflavone inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA]; 5,7-dimethoxyflavone inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 protein] 5,7-dimethoxyflavone results in decreased activity of CYP1A1 protein |
CTD |
PMID:15661813 PMID:15905203 PMID:16484233 |
|
NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
|
|
G |
CYP1B1 |
cytochrome P450 family 1 subfamily B member 1 |
multiple interactions decreases activity |
EXP |
5,7-dimethoxyflavone inhibits the reaction [Benzo(a)pyrene results in increased activity of CYP1B1 protein]; 5,7-dimethoxyflavone inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1B1 mRNA]; 5,7-dimethoxyflavone inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1B1 protein] 5,7-dimethoxyflavone results in decreased activity of CYP1B1 protein |
CTD |
PMID:15905203 PMID:16484233 PMID:16530937 |
|
NCBI chr 2:38,067,509...38,076,151
Ensembl chr 2:38,066,973...38,109,902
|
|
G |
GSK3B |
glycogen synthase kinase 3 beta |
multiple interactions |
ISO |
5,7-dimethoxyflavone promotes the reaction [Diethylnitrosamine results in increased phosphorylation of GSK3B protein] |
CTD |
PMID:21554863 |
|
NCBI chr 3:119,821,321...120,094,447
Ensembl chr 3:119,821,321...120,094,994
|
|
G |
IL1B |
interleukin 1 beta |
multiple interactions |
EXP |
5,7-dimethoxyflavone inhibits the reaction [IL1B protein results in increased secretion of CCL2 protein]; 5,7-dimethoxyflavone inhibits the reaction [IL1B protein results in increased secretion of CXCL8 protein]; 5,7-dimethoxyflavone inhibits the reaction [IL1B protein results in increased secretion of IL6 protein] |
CTD |
PMID:24134915 |
|
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
IL6 |
interleukin 6 |
multiple interactions |
EXP |
5,7-dimethoxyflavone inhibits the reaction [IL1B protein results in increased secretion of IL6 protein] |
CTD |
PMID:24134915 |
|
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
NOS2 |
nitric oxide synthase 2 |
multiple interactions |
ISO |
5,7-dimethoxyflavone inhibits the reaction [Diethylnitrosamine results in increased expression of NOS2 protein] |
CTD |
PMID:21554863 |
|
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
5,7-dimethoxyflavone inhibits the reaction [Diethylnitrosamine results in increased expression of PTGS2 mRNA]; 5,7-dimethoxyflavone inhibits the reaction [Diethylnitrosamine results in increased expression of PTGS2 protein] |
CTD |
PMID:21554863 |
|
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
|
|
G |
RELA |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
5,7-dimethoxyflavone inhibits the reaction [Diethylnitrosamine results in increased expression of RELA mRNA]; 5,7-dimethoxyflavone inhibits the reaction [Diethylnitrosamine results in increased expression of RELA protein modified form] |
CTD |
PMID:21554863 |
|
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
|
|
G |
TP53 |
tumor protein p53 |
multiple interactions |
ISO |
[5,7-dimethoxyflavone co-treated with Diethylnitrosamine] results in increased expression of TP53 mRNA; [5,7-dimethoxyflavone co-treated with Diethylnitrosamine] results in increased expression of TP53 protein |
CTD |
PMID:21554863 |
|
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538
|
|
G |
WNT3A |
Wnt family member 3A |
multiple interactions |
ISO |
5,7-dimethoxyflavone inhibits the reaction [Diethylnitrosamine results in increased expression of WNT3A protein] |
CTD |
PMID:21554863 |
|
NCBI chr 1:228,006,998...228,061,271
Ensembl chr 1:228,006,998...228,061,271
|
|